Ontuxizumab (MORAb-004) is a monoclonal antibody targeting endomelanic acid with anti-tumor effects.Ontuxizumab is a potent IgG1/kappa anti-endothelin (TEM-1 or CD248) monoclonal antibody for the treatment of metastatic melanoma.
CAS Number:
[946415-62-9]
Target:
MORAb-004
* VAT and and shipping costs not included. Errors and price changes excepted